Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Exclusion Criteria

• •Presence of an advanced, severe, progressive, or unstable disease of any type that could interfere with efficacy and safety assessments or put the patient at particular risk,
• •Any medical or neurological condition other than Alzheimers Disease that could explain the patient's dementia,
• •A diagnosis of probable or possible vascular dementia,
• •A current diagnosis of unsuccessfully-treated depression, or any other mental disorder that may interfere with the evaluation of the patient's response to study medication,
• •A history or current diagnosis of cerebrovascular disease (e.g. stroke),
• •A current diagnosis of severe or unstable cardiovascular disease (e.g. unstable coronary artery disease).